Low postpandemic wave SARS-CoV-2 seroprevalence in Kuala Lumpur and Selangor, Malaysia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis.European journal of medical research · 2022
   Pooled it
2. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021
   Pooled it
3. A community based seroprevalence of SARS-CoV-2 antibodies in Somali Region, Eastern Ethiopia.Immunity, inflammation and disease · 2024
   Article
4. The seroprevalence of SARS-CoV-2 infection in Malaysia: 7 August to 11 October 2020.Influenza and other respiratory viruses · 2023
   Article
5. Twice evasions of Omicron variants explain the temporal patterns in six Asian and Oceanic countries.BMC infectious diseases · 2023
   Article
6. Estimating the infection burden of COVID-19 in Malaysia.PLoS neglected tropical diseases · 2022
   Article
7. Low Seroprevalence of SARS-CoV-2 among Healthcare Workers in Malaysia during the Third COVID-19 Wave: Prospective Study with Literature Survey on Infection Prevention and Control Measures.Healthcare (Basel, Switzerland) · 2022
   Article
8. Changing predominant SARS-CoV-2 lineages drives successive COVID-19 waves in Malaysia, February 2020 to March 2021.Journal of medical virology · 2022
   Article
9. Did Laos really control the transmission of SARS-CoV-2 in 2020?The Lancet regional health. Western Pacific · 2021
   Article
10. Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam.International journal of environmental research and public health · 2021
    Article
11. Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
12. Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia.The Lancet regional health. Western Pacific · 2021
    Article
13. Antibody Responses in COVID-19: A Review.Frontiers in immunology · 2021
    Review
14. The Pandemic Experience in Southeast Asia: Interface Between SARS-CoV-2, Malaria, and Dengue.Frontiers in tropical diseases · 2021
    Article
15. Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020
    Review
16. Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020.Western Pacific surveillance and response journal : WPSAR
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as